Oakley Capital Origin II managed by Oakley Capital Investments Limited agreed to acquire an unknown majority stake in vitroconnect systems GmbH on May 14, 2024. Oakley is investing alongside Dirk Pasternack and his management team who will continue to run the business. The transaction is subject to regulatory approval and is expected to complete around the end of first half of 2024.
Benjamin Leyendecker, Greta-Josefin Harnisch of Kirkland & Ellis LLP acted as legal advisor to Oakley Capital Investments Limited. Hans ?Peter? Leube, Marianne Nawroth, Walter Ahrens, Karsten Emmermann and Michael Masling of Morgan, Lewis & Bockius LLP acted as legal advisor to shareholders of vitroconnect systems GmbH.